Publicaciones en colaboración con investigadores/as de Instituto Cajal (10)

2011

  1. Framework for sex differences in adolescent neurobiology: A focus on cannabinoids

    Neuroscience and Biobehavioral Reviews, Vol. 35, Núm. 8, pp. 1740-1751

2008

  1. Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system

    Developmental Neurobiology, Vol. 68, Núm. 11, pp. 1334-1347

2007

  1. Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats

    Psychoneuroendocrinology, Vol. 32, Núm. 6, pp. 636-650

2006

  1. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats

    Behavioural Brain Research, Vol. 172, Núm. 1, pp. 46-53

2005

  1. Behavioral, endocrine and immunological characteristics of a murine model of premature aging

    Developmental and Comparative Immunology, Vol. 29, Núm. 11, pp. 965-976

  2. The κ-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety

    Behavioural Brain Research, Vol. 163, Núm. 2, pp. 212-218

2004

  1. Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: Influence of weaning

    Pharmacology Biochemistry and Behavior

  2. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats

    Behavioural Pharmacology, Vol. 15, Núm. 1, pp. 21-27

2003

  1. Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood

    Psychopharmacology, Vol. 170, Núm. 3, pp. 301-308

  2. Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats

    Pharmacology Biochemistry and Behavior, Vol. 74, Núm. 3, pp. 649-656